Saturday, January 19, 2019 12:02:04 PM
Very risky move for investors, imho.
Do some research on the subject and historical outcomes of reverse splits. Pretty scary. Whatever this company has been doing thus far has not attracted new investors no matter how much good it has going for it. Still a lot of grey and unknowns. Still no evidence that Poda vape is an actual product, GTEC deal fell apart, lot's of management turnover, no updates on phase expansions, and Gene Simmons "issues".
As I have mentioned before, monitoring for the "right" buy-in point. If the company uplisting is approved and the RS brings the share value to say $7 CAD on Gene ticker and approximately $5 on IVITF the price could easily hit $3 CAD within a week or two of NASDAQ listing.
So my buy-in point would still be on target at pre-split assessment around the $0.50 (or less) CAD range.
Doesn't take "stones" to stay in a stock that is loosing value and is constantly putting their investors at significant risk.
Good luck to everyone on your investments and decisions.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM